Core Insights - The company, Jieqiang Equipment, has completed the acquisition of a 51% stake in Shandong Tanxun New Materials, marking a strategic move to expand its growth trajectory while solidifying its core business in nuclear and biochemical safety equipment [1][2]. Group 1: Acquisition Details - The acquisition was finalized on October 10, with a total payment of 46.9 million yuan made in three phases, and Shandong Tanxun has officially become a subsidiary of Jieqiang Equipment [1]. - The rapid completion of the acquisition process, from board approval on September 15 to business registration on September 30, highlights the company's strategic commitment to growth [1]. Group 2: Company Background - Jieqiang Equipment has over 20 years of experience in the nuclear and biochemical safety equipment sector, offering more than 100 products, including radiation monitoring and biological detection equipment [1]. - The company's products are utilized across various fields such as environmental protection, healthcare, and nuclear industry applications, demonstrating its established market presence [1]. Group 3: Financial Performance and Future Strategy - In 2024, Shandong Tanxun reported revenues of 17.65 million yuan and a net profit of 0.8579 million yuan, with a strong growth trend observed in the first five months of 2025, achieving revenues of 64.1 million yuan and a net profit of 6.12 million yuan [3]. - Jieqiang Equipment aims to enhance its core competitiveness and profitability through the integration of resources and the development of a comprehensive nuclear and biochemical safety equipment system [2][3]. - The company plans to leverage its core business while exploring high-growth sectors, positioning itself for a new phase of value re-evaluation amid increasing demand for nuclear safety and rapid expansion in the new energy industry [3].